Menu
  1. Dashboard

Amgen Inc. NASDAQ: AMGN

Invest Fact Sheet

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience

Name Amgen Inc.
Ticker AMGN
Exchange NASDAQ
Sector Health Care
Industry Biopharmaceuticals
Price 194.08
52W Low/High 166.70 / 208.89
Market cap 116 B
1Y Total Return -0.53%
1Y Volatility 24.43%
Below Average
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience

Details

Ticker AMGN
Name Amgen Inc.
ISIN US0311621009
CUSIP 126650100
Exchange NASDAQ
Sector Health Care
Industry Biopharmaceuticals
Country USA
Currency U.S. Dollar
In Index(ices)
  • US S&P 500 Index
  • Nasdaq 100 Index
  • NASDAQ Biotechnology Index
  • US S&P 100 Index

Share as of 9/16/19

Close Price 194.08
52W Low/High 166.70 / 208.89
Market cap 116 B
1Y Total Return -0.53%
1Y Volatility 24.43%
Below Average
Beta 1.31
PE (trailing) 15.38
Below Average
12M Dividends 5.54
Last Dividend Date 8/14/19
Dividend Yield 2.85%

Fin. Strength

Net Profit Margin 33.8%
Cash from Op. / Cur. Liabilities 0.92
Diluted Earnings / Share 12.62
ROE 61.9%
ROIC 20.5%
Price / Revenue 5.0
Price / Book 11.0
Price / CF 12.2
Current Ratio 2.9
Cur.Liabilities / Tot.Liabilities 0.2
Financial Leverage 2.6
in Mils USD
rolling-year up to June
 
Income Statement 2019 2018 2017 2016 2015 2014  
Revenue
23,562
23,188
23,050
22,474
20,765
19,460
Gross Profit
19,362
19,171
18,936
18,301
16,392
15,472
R&D
3,911
3,549
3,710
3,984
4,110
4,283
Operating Income
9,855
10,242
10,301
9,154
7,023
6,141
Net Income exc. Extra
7,958
2,364
8,174
7,433
5,814
5,009
per Share  
Diluted avg Shares
610
660
738
756
768
768
EPS exc. Extra
12.62
3.72
10.99
9.77
7.55
6.53
Dividend
5.54
4.94
4.30
3.58
2.80
2.16
  
Div. Yield (an.)
3.14%
2.57%
2.44%
2.08%
1.59%
1.69%
  
Balance Sheet 2019 2018 2017 2016 2015 2014  
Total Assets
59,373
67,684
79,587
75,471
71,209
69,534
Cash, Eq & Invt ShortTerm
21,758
29,395
39,227
35,034
29,993
26,188
Total Current Assets
30,746
37,970
48,442
42,947
37,736
34,328
Total Non-Current Assets
28,627
29,714
31,145
32,524
33,473
35,206
Intangibles
21,502
23,167
24,327
25,867
26,711
28,343
Total Liabilities
48,579
52,775
47,865
45,338
43,725
45,152
Total Current Liabilities
10,622
11,205
7,815
10,830
6,891
7,866
Long Term Debt
37,957
41,570
40,050
34,508
36,834
37,286
Shareholder equity
10,794
14,909
31,722
30,133
27,484
24,382
Cash Flow 2019 2018 2017 2016 2015 2014  
Cash from Operations
9,726
11,295
10,473
9,526
9,329
7,011
Depreciation
1,987
1,868
2,104
2,108
2,111
1,756
Cash from Investing
2,795
15,790
-5,581
-7,283
-5,840
-15,460
Capex
656
642
683
625
398
721
Cash from Financing
-17,127
-19,583
-4,893
-3,408
-4,046
6,995
Stock Issued
-9,300
-15,539
-3,254
-2,115
-939
183
Debt (LT) Issued
-4,271
-468
1,724
1,659
-936
8,304
Free Cash Flow
9,422
7,228
6,788
13,128
7,544
9,530
Ratios 2019 2018 2017 2016 2015 2014  
Net Profit Margin
33.8%
10.2%
35.5%
33.1%
28.0%
25.7%
  
NCFO / Op.Income
98.7%
110.3%
101.7%
104.1%
132.8%
114.2%
  
Current Ratio
2.9
3.4
6.2
4.0
5.5
4.4
  
Financial Leverage D/E
2.6
2.0
1.1
0.9
1.1
1.3
  
Return on Capital Avg
20.5%
4.7%
14.1%
13.8%
11.5%
12.0%
  
Return on Shareholder Equity
61.9%
10.1%
26.4%
25.8%
22.4%
22.3%
  

No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available